| Year |
Citation |
Score |
| 2012 |
Endicott JA, Noble ME, Johnson LN. The structural basis for control of eukaryotic protein kinases. Annual Review of Biochemistry. 81: 587-613. PMID 22482904 DOI: 10.1146/Annurev-Biochem-052410-090317 |
0.628 |
|
| 2011 |
Johnson LN. Substrates of mitotic kinases. Science Signaling. 4: pe31. PMID 21712544 DOI: 10.1126/Scisignal.2002234 |
0.367 |
|
| 2010 |
Baumli S, Endicott JA, Johnson LN. Halogen bonds form the basis for selective P-TEFb inhibition by DRB Chemistry and Biology. 17: 931-936. PMID 20851342 DOI: 10.1016/J.Chembiol.2010.07.012 |
0.402 |
|
| 2009 |
Johnson LN. The regulation of protein phosphorylation. Biochemical Society Transactions. 37: 627-41. PMID 19614568 DOI: 10.1042/Bst0370627 |
0.405 |
|
| 2009 |
Johnson LN. Protein kinase inhibitors: contributions from structure to clinical compounds. Quarterly Reviews of Biophysics. 42: 1-40. PMID 19296866 DOI: 10.1017/S0033583508004745 |
0.389 |
|
| 2009 |
Vénien-Bryan C, Jonic S, Skamnaki V, Brown N, Bischler N, Oikonomakos NG, Boisset N, Johnson LN. The structure of phosphorylase kinase holoenzyme at 9.9 angstroms resolution and location of the catalytic subunit and the substrate glycogen phosphorylase. Structure (London, England : 1993). 17: 117-27. PMID 19141288 DOI: 10.1016/J.Str.2008.10.013 |
0.428 |
|
| 2009 |
Davies KM, Lowe ED, Vénien-Bryan C, Johnson LN. The HupR receiver domain crystal structure in its nonphospho and inhibitory phospho states. Journal of Molecular Biology. 385: 51-64. PMID 18977359 DOI: 10.1016/J.Jmb.2008.10.027 |
0.388 |
|
| 2008 |
Lowe ED, Gao GY, Johnson LN, Keung WM. Structure of daidzin, a naturally occurring anti-alcohol-addiction agent, in complex with human mitochondrial aldehyde dehydrogenase. Journal of Medicinal Chemistry. 51: 4482-7. PMID 18613661 DOI: 10.1021/Jm800488J |
0.305 |
|
| 2008 |
Baumli S, Lolli G, Lowe ED, Troiani S, Rusconi L, Bullock AN, Debreczeni JE, Knapp S, Johnson LN. The structure of P-TEFb (CDK9/cyclin T1), its complex with flavopiridol and regulation by phosphorylation. The Embo Journal. 27: 1907-18. PMID 18566585 DOI: 10.1038/Emboj.2008.121 |
0.401 |
|
| 2008 |
Johnson TM, Antrobus R, Johnson LN. Plk1 activation by Ste20-like kinase (Slk) phosphorylation and polo-box phosphopeptide binding assayed with the substrate translationally controlled tumor protein (TCTP). Biochemistry. 47: 3688-96. PMID 18298087 DOI: 10.1021/Bi702134C |
0.411 |
|
| 2007 |
Brown NR, Lowe ED, Petri E, Skamnaki V, Antrobus R, Johnson LN. Cyclin B and cyclin A confer different substrate recognition properties on CDK2. Cell Cycle (Georgetown, Tex.). 6: 1350-9. PMID 17495531 DOI: 10.4161/Cc.6.11.4278 |
0.42 |
|
| 2007 |
Lolli G, Johnson LN. Recognition of Cdk2 by Cdk7. Proteins. 67: 1048-59. PMID 17373709 DOI: 10.1002/Prot.21370 |
0.408 |
|
| 2007 |
Johnson L. Protein kinases and their therapeutic exploitation Biochemical Society Transactions. 35: 7-11. PMID 17212579 DOI: 10.1042/Bst0350007 |
0.419 |
|
| 2006 |
Cheng KY, Noble ME, Skamnaki V, Brown NR, Lowe ED, Kontogiannis L, Shen K, Cole PA, Siligardi G, Johnson LN. The role of the phospho-CDK2/cyclin A recruitment site in substrate recognition. The Journal of Biological Chemistry. 281: 23167-79. PMID 16707497 DOI: 10.1074/Jbc.M600480200 |
0.583 |
|
| 2006 |
Davies KM, Skamnaki V, Johnson LN, Vénien-Bryan C. Structural and functional studies of the response regulator HupR. Journal of Molecular Biology. 359: 276-88. PMID 16631791 DOI: 10.1016/J.Jmb.2006.02.072 |
0.348 |
|
| 2006 |
Geremia S, Campagnolo M, Demitri N, Johnson LN. Simulation of diffusion time of small molecules in protein crystals. Structure (London, England : 1993). 14: 393-400. PMID 16531224 DOI: 10.1016/J.Str.2005.12.007 |
0.313 |
|
| 2006 |
Lowe ED, Hasan N, Trempe JF, Fonso L, Noble ME, Endicott JA, Johnson LN, Brown NR. Structures of the Dsk2 UBL and UBA domains and their complex. Acta Crystallographica. Section D, Biological Crystallography. 62: 177-88. PMID 16421449 DOI: 10.1107/S0907444905037777 |
0.543 |
|
| 2006 |
Blake CCF, Fenn RH, Johnson LN, Koenig DF, Mair GA, North ACT, Oldham JWH, Phillips DC, Poljak RJ, Sarma VR, Vernon CA. How the structure of lysozyme was actually determined International Tables For Crystallography. DOI: 10.1107/97809553602060000725 |
0.365 |
|
| 2005 |
Passmore LA, Booth CR, Vénien-Bryan C, Ludtke SJ, Fioretto C, Johnson LN, Chiu W, Barford D. Structural analysis of the anaphase-promoting complex reveals multiple active sites and insights into polyubiquitylation. Molecular Cell. 20: 855-66. PMID 16364911 DOI: 10.1016/J.Molcel.2005.11.003 |
0.356 |
|
| 2005 |
Noble M, Barrett P, Endicott J, Johnson L, McDonnell J, Robertson G, Zawaira A. Exploiting structural principles to design cyclin-dependent kinase inhibitors. Biochimica Et Biophysica Acta. 1754: 58-64. PMID 16361058 DOI: 10.1016/J.Bbapap.2005.08.019 |
0.575 |
|
| 2005 |
Kuo A, Domene C, Johnson LN, Doyle DA, Vénien-Bryan C. Two different conformational states of the KirBac3.1 potassium channel revealed by electron crystallography. Structure (London, England : 1993). 13: 1463-72. PMID 16216578 DOI: 10.1016/J.Str.2005.07.011 |
0.302 |
|
| 2005 |
Lolli G, Johnson LN. CAK-Cyclin-dependent Activating Kinase: a key kinase in cell cycle control and a target for drugs? Cell Cycle (Georgetown, Tex.). 4: 572-7. PMID 15876871 DOI: 10.4161/Cc.4.4.1607 |
0.379 |
|
| 2005 |
Cook AG, Johnson LN, McDonnell JM. Structural characterization of Ca2+/CaM in complex with the phosphorylase kinase PhK5 peptide. The Febs Journal. 272: 1511-22. PMID 15752366 DOI: 10.1111/J.1742-4658.2005.04591.X |
0.336 |
|
| 2005 |
Honda R, Lowe ED, Dubinina E, Skamnaki V, Cook A, Brown NR, Johnson LN. The structure of cyclin E1/CDK2: implications for CDK2 activation and CDK2-independent roles. The Embo Journal. 24: 452-63. PMID 15660127 DOI: 10.1038/Sj.Emboj.7600554 |
0.38 |
|
| 2005 |
Johnson LN. Protein kinase inhibition and substrate recognition Acta Crystallographica Section a Foundations of Crystallography. 61: c4-c4. DOI: 10.1107/S0108767305099824 |
0.386 |
|
| 2005 |
Wilson CC, Myles D, Ghosh M, Johnson LN, Wang W. Neutron diffraction investigations of L- and D-alanine at different temperatures: The search for structural evidence for parity violation New Journal of Chemistry. 29: 1318-1322. DOI: 10.1039/B419295H |
0.307 |
|
| 2004 |
Lolli G, Lowe ED, Brown NR, Johnson LN. The crystal structure of human CDK7 and its protein recognition properties. Structure (London, England : 1993). 12: 2067-79. PMID 15530371 DOI: 10.1016/J.Str.2004.08.013 |
0.444 |
|
| 2004 |
Noble ME, Endicott JA, Johnson LN. Protein kinase inhibitors: insights into drug design from structure. Science (New York, N.Y.). 303: 1800-5. PMID 15031492 DOI: 10.1126/Science.1095920 |
0.59 |
|
| 2003 |
Cheng KY, Lowe ED, Sinclair J, Nigg EA, Johnson LN. The crystal structure of the human polo-like kinase-1 polo box domain and its phospho-peptide complex. The Embo Journal. 22: 5757-68. PMID 14592974 DOI: 10.1093/Emboj/Cdg558 |
0.407 |
|
| 2003 |
De Moliner E, Brown NR, Johnson LN. Alternative binding modes of an inhibitor to two different kinases. European Journal of Biochemistry / Febs. 270: 3174-81. PMID 12869192 DOI: 10.1046/J.1432-1033.2003.03697.X |
0.444 |
|
| 2003 |
Mesguiche V, Parsons RJ, Arris CE, Bentley J, Boyle FT, Curtin NJ, Davies TG, Endicott JA, Gibson AE, Golding BT, Griffin RJ, Jewsbury P, Johnson LN, Newell DR, Noble ME, et al. 4-Alkoxy-2,6-diaminopyrimidine derivatives: inhibitors of cyclin dependent kinases 1 and 2. Bioorganic & Medicinal Chemistry Letters. 13: 217-22. PMID 12482427 DOI: 10.1016/S0960-894X(02)00884-3 |
0.584 |
|
| 2002 |
Lowe ED, Tews I, Cheng KY, Brown NR, Gul S, Noble ME, Gamblin SJ, Johnson LN. Specificity determinants of recruitment peptides bound to phospho-CDK2/cyclin A. Biochemistry. 41: 15625-34. PMID 12501191 DOI: 10.1021/Bi0268910 |
0.584 |
|
| 2002 |
Davies TG, Bentley J, Arris CE, Boyle FT, Curtin NJ, Endicott JA, Gibson AE, Golding BT, Griffin RJ, Hardcastle IR, Jewsbury P, Johnson LN, Mesguiche V, Newell DR, Noble ME, et al. Structure-based design of a potent purine-based cyclin-dependent kinase inhibitor. Nature Structural Biology. 9: 745-9. PMID 12244298 DOI: 10.1038/Nsb842 |
0.581 |
|
| 2002 |
Geremia S, Campagnolo M, Schinzel R, Johnson LN. Enzymatic catalysis in crystals of Escherichia coli maltodextrin phosphorylase. Journal of Molecular Biology. 322: 413-23. PMID 12217700 DOI: 10.1016/S0022-2836(02)00771-4 |
0.428 |
|
| 2002 |
Davies TG, Pratt DJ, Endicott JA, Johnson LN, Noble ME. Structure-based design of cyclin-dependent kinase inhibitors. Pharmacology & Therapeutics. 93: 125-33. PMID 12191605 DOI: 10.1016/S0163-7258(02)00182-1 |
0.616 |
|
| 2002 |
Johnson LN, De Moliner E, Brown NR, Song H, Barford D, Endicott JA, Noble ME. Structural studies with inhibitors of the cell cycle regulatory kinase cyclin-dependent protein kinase 2. Pharmacology & Therapeutics. 93: 113-24. PMID 12191604 DOI: 10.1016/S0163-7258(02)00181-X |
0.623 |
|
| 2002 |
Gibson AE, Arris CE, Bentley J, Boyle FT, Curtin NJ, Davies TG, Endicott JA, Golding BT, Grant S, Griffin RJ, Jewsbury P, Johnson LN, Mesguiche V, Newell DR, Noble ME, et al. Probing the ATP ribose-binding domain of cyclin-dependent kinases 1 and 2 with O(6)-substituted guanine derivatives. Journal of Medicinal Chemistry. 45: 3381-93. PMID 12139449 DOI: 10.1021/Jm020056Z |
0.587 |
|
| 2002 |
Cook A, Lowe ED, Chrysina ED, Skamnaki VT, Oikonomakos NG, Johnson LN. Structural studies on phospho-CDK2/cyclin A bound to nitrate, a transition state analogue: implications for the protein kinase mechanism. Biochemistry. 41: 7301-11. PMID 12044161 DOI: 10.1021/Bi0201724 |
0.463 |
|
| 2002 |
Vénien-Bryan C, Lowe EM, Boisset N, Traxler KW, Johnson LN, Carlson GM. Three-dimensional structure of phosphorylase kinase at 22 A resolution and its complex with glycogen phosphorylase b. Structure (London, England : 1993). 10: 33-41. PMID 11796108 DOI: 10.1016/S0969-2126(01)00691-8 |
0.443 |
|
| 2001 |
Johnson LN, Lewis RJ. Structural basis for control by phosphorylation. Chemical Reviews. 101: 2209-42. PMID 11749371 DOI: 10.1021/Cr000225S |
0.377 |
|
| 2001 |
Lawrie AM, Tito P, Hernandez H, Brown NR, Robinson CV, Endicott JA, Noble ME, Johnson LN. Xenopus phospho-CDK7/cyclin H expressed in baculoviral-infected insect cells. Protein Expression and Purification. 23: 252-60. PMID 11676600 DOI: 10.1006/Prep.2001.1504 |
0.584 |
|
| 2001 |
Song H, Hanlon N, Brown NR, Noble ME, Johnson LN, Barford D. Phosphoprotein-protein interactions revealed by the crystal structure of kinase-associated phosphatase in complex with phosphoCDK2. Molecular Cell. 7: 615-26. PMID 11463386 DOI: 10.1016/S1097-2765(01)00208-8 |
0.624 |
|
| 2001 |
Johnson LN. Structural basis for substrate recognition and control in protein kinases. Ernst Schering Research Foundation Workshop. 47-69. PMID 11394047 |
0.307 |
|
| 2000 |
Stubbe J, Johnson LN. Clarity through structures. Editorial overview. Current Opinion in Structural Biology. 10: 709-710. PMID 11114508 DOI: 10.1016/S0959-440X(00)00160-3 |
0.316 |
|
| 2000 |
Ghosh M, Meerts IA, Cook A, Bergman A, Brouwer A, Johnson LN. Structure of human transthyretin complexed with bromophenols: a new mode of binding. Acta Crystallographica. Section D, Biological Crystallography. 56: 1085-95. PMID 10957627 DOI: 10.1107/S0907444900008568 |
0.323 |
|
| 2000 |
Arris CE, Boyle FT, Calvert AH, Curtin NJ, Endicott JA, Garman EF, Gibson AE, Golding BT, Grant S, Griffin RJ, Jewsbury P, Johnson LN, Lawrie AM, Newell DR, Noble ME, et al. Identification of novel purine and pyrimidine cyclin-dependent kinase inhibitors with distinct molecular interactions and tumor cell growth inhibition profiles. Journal of Medicinal Chemistry. 43: 2797-804. PMID 10956187 DOI: 10.1021/Jm990628O |
0.56 |
|
| 2000 |
Oikonomakos NG, Schnier JB, Zographos SE, Skamnaki VT, Tsitsanou KE, Johnson LN. Flavopiridol inhibits glycogen phosphorylase by binding at the inhibitor site. The Journal of Biological Chemistry. 275: 34566-73. PMID 10924512 DOI: 10.1074/Jbc.M004485200 |
0.387 |
|
| 2000 |
Oikonomakos NG, Skamnaki VT, Tsitsanou KE, Gavalas NG, Johnson LN. A new allosteric site in glycogen phosphorylase b as a target for drug interactions. Structure (London, England : 1993). 8: 575-84. PMID 10873856 DOI: 10.1016/S0969-2126(00)00144-1 |
0.401 |
|
| 2000 |
Noble M, Arold S, Brown N, Campbell I, Endicott JA, Gruber J, Johnson L, Ladbury J, Tucker J, Ulmer T. Molecular recognition in the action of protein kinases: the basis for affinity and specificity Acta Crystallographica Section a Foundations of Crystallography. 56: s102-s102. DOI: 10.1107/S010876730002273X |
0.572 |
|
| 1999 |
Brown NR, Noble ME, Endicott JA, Johnson LN. The structural basis for specificity of substrate and recruitment peptides for cyclin-dependent kinases. Nature Cell Biology. 1: 438-43. PMID 10559988 DOI: 10.1038/15674 |
0.61 |
|
| 1999 |
Skamnaki VT, Owen DJ, Noble ME, Lowe ED, Lowe G, Oikonomakos NG, Johnson LN. Catalytic mechanism of phosphorylase kinase probed by mutational studies. Biochemistry. 38: 14718-30. PMID 10545198 DOI: 10.1021/Bi991454F |
0.619 |
|
| 1999 |
Watson KA, McCleverty C, Geremia S, Cottaz S, Driguez H, Johnson LN. Phosphorylase recognition and phosphorolysis of its oligosaccharide substrate: answers to a long outstanding question. The Embo Journal. 18: 4619-32. PMID 10469642 DOI: 10.1093/Emboj/18.17.4619 |
0.402 |
|
| 1999 |
Johnson LN, Petsko GA. David Phillips and the origin of structural enzymology Trends in Biochemical Sciences. 24: 287-289. PMID 10390620 DOI: 10.1016/S0968-0004(99)01423-1 |
0.497 |
|
| 1999 |
Johnson LN, Petsko GA. David Phillips (1924-99) Nature. 399: 26. PMID 10331385 DOI: 10.1038/19878 |
0.487 |
|
| 1999 |
O'Reilly M, Watson KA, Johnson LN. The crystal structure of the Escherichia coli maltodextrin phosphorylase-acarbose complex Biochemistry. 38: 5337-5345. PMID 10220320 DOI: 10.1021/Bi9828573 |
0.412 |
|
| 1999 |
Tsitsanou KE, Oikonomakos NG, Zographos SE, Skamnaki VT, Gregoriou M, Watson KA, Johnson LN, Fleet GW. Effects of commonly used cryoprotectants on glycogen phosphorylase activity and structure. Protein Science : a Publication of the Protein Society. 8: 741-9. PMID 10211820 DOI: 10.1110/Ps.8.4.741 |
0.417 |
|
| 1999 |
Brown NR, Noble ME, Lawrie AM, Morris MC, Tunnah P, Divita G, Johnson LN, Endicott JA. Effects of phosphorylation of threonine 160 on cyclin-dependent kinase 2 structure and activity. The Journal of Biological Chemistry. 274: 8746-56. PMID 10085115 DOI: 10.1074/Jbc.274.13.8746 |
0.609 |
|
| 1999 |
Johnson LN. PROTEIN KINASE STRUCTURE AND MECHANISM Biochemical Society Transactions. 27: A1-A1. DOI: 10.1042/Bst027A001C |
0.403 |
|
| 1999 |
Johnson LN, Noble MEM, Barford D, Brown N, Endicott JA, Lawrie A, Owen DJ. Signal Transduction Proteins: Structural Basis of Control by Phosphorylation Journal of Chemical Society of Pakistan. 21: 185-201. |
0.51 |
|
| 1998 |
Johnson LN, Lowe ED, Noble ME, Owen DJ. The Eleventh Datta Lecture. The structural basis for substrate recognition and control by protein kinases Febs Letters. 430: 1-11. PMID 9678585 DOI: 10.1016/S0014-5793(98)00606-1 |
0.598 |
|
| 1998 |
Gregoriou M, Noble ME, Watson KA, Garman EF, Krulle TM, de la Fuente C, Fleet GW, Oikonomakos NG, Johnson LN. The structure of a glycogen phosphorylase glucopyranose spirohydantoin complex at 1.8 A resolution and 100 K: the role of the water structure and its contribution to binding. Protein Science : a Publication of the Protein Society. 7: 915-27. PMID 9568898 DOI: 10.1002/Pro.5560070409 |
0.577 |
|
| 1998 |
Endicott J, Noble M, Lawrie A, Tunnah P, Brown N, Johnson L, Calvert A, Curtin N, Golding B, Griffin R, Newell. Insights into CDK inhibitor design from X-ray crystallographic studies Annals of Oncology. DOI: 10.1093/Annonc/9.Suppl_2.3 |
0.521 |
|
| 1998 |
Grant S, Boyle F, Calvert A, Curtin N, Endicott J, Golding B, Griffin R, Johnson L, Newell, Noble M, Robson C. O-6-alkylguanines as selective inhibitors of cyclin dependent kinases Annals of Oncology. DOI: 10.1093/Annonc/9.Suppl_2.132 |
0.32 |
|
| 1998 |
Johnson LN, Lowe ED, Noble MEM, Owen DJ. The structural basis for substrate recognition and control by protein kinases Febs Letters. 430: 1-11. DOI: 10.1016/S0014-5793(98)00606-1 |
0.558 |
|
| 1997 |
Noble ME, Endicott JA, Brown NR, Johnson LN. The cyclin box fold: protein recognition in cell-cycle and transcription control. Trends in Biochemical Sciences. 22: 482-7. PMID 9433129 DOI: 10.1016/S0968-0004(97)01144-4 |
0.536 |
|
| 1997 |
Zographos SE, Oikonomakos NG, Tsitsanou KE, Leonidas DD, Chrysina ED, Skamnaki VT, Bischoff H, Goldmann S, Watson KA, Johnson LN. The structure of glycogen phosphorylase b with an alkyl-dihydropyridine-dicarboxylic acid compound, a novel and potent inhibitor Structure. 5: 1413-1425. PMID 9384557 DOI: 10.1016/S0969-2126(97)00292-X |
0.34 |
|
| 1997 |
Lowe ED, Noble MEM, Skamnaki VT, Oikonomakos NG, Owen DJ, Johnson LN. The crystal structure of a phosphorylase kinase peptide substrate complex: Kinase substrate recognition Embo Journal. 16: 6646-6658. PMID 9362479 DOI: 10.1093/Emboj/16.22.6646 |
0.609 |
|
| 1997 |
Lawrie AM, Noble ME, Tunnah P, Brown NR, Johnson LN, Endicott JA. Protein kinase inhibition by staurosporine revealed in details of the molecular interaction with CDK2. Nature Structural Biology. 4: 796-801. PMID 9334743 DOI: 10.1038/Nsb1097-796 |
0.414 |
|
| 1997 |
O'Reilly M, Watson KA, Schinzel R, Palm D, Johnson LN. Oligosaccharide substrate binding in Escherichia coli maltodextrin phosphorylase Nature Structural Biology. 4: 405-412. PMID 9145112 DOI: 10.1038/Nsb0597-405 |
0.419 |
|
| 1997 |
Watson KA, Schinzel R, Palm D, Johnson LN. The crystal structure of Escherichia coli maltodextrin phosphorylase provides an explanation for the activity without control in this basic archetype of a phosphorylase Embo Journal. 16: 1-14. PMID 9009262 DOI: 10.1093/Emboj/16.1.1 |
0.381 |
|
| 1997 |
De La Fuente C, Krülle TM, Watson KA, Gregoriou M, Johnson LN, Tsitsanou KE, Zographos SE, Oikonomakos NG, Fleet GWJ. Glucopyranose spirohydantoins: Specific inhibitors of glycogen phosphorylase Synlett. 485-487. DOI: 10.1055/S-1997-940277 |
0.309 |
|
| 1997 |
Johnson LN, Barford D, Owen DJ, Noble MEM, Garman EF. From phosphorylase to phosphorylase kinase. Advances in Second Messenger and Phosphoprotein Research. 31: 11-28. DOI: 10.1007/978-3-642-60848-3_2 |
0.39 |
|
| 1997 |
Johnson LN, Brown NR, Endicoti JA, Lawrie AM, Löwe ED, Noble MEM, Tunnah P. The structural basis for control by phosphorylation Faseb Journal. 11: A1011. |
0.526 |
|
| 1996 |
Johnson LN, O'Reilly M. Control by phosphorylation Current Opinion in Structural Biology. 6: 762-769. PMID 8994876 DOI: 10.1016/S0959-440X(96)80005-4 |
0.441 |
|
| 1996 |
Oikonomakos NG, Zographos SE, Tsitsanou KE, Johnson LN, Acharya KR. Activator anion binding site in pyridoxal phosphorylase b: The binding of phosphite, phosphate, and fluorophosphate in the crystal Protein Science. 5: 2416-2428. PMID 8976550 DOI: 10.1002/Pro.5560051204 |
0.432 |
|
| 1996 |
Mitchell EP, Withers SG, Ermert P, Vasella AT, Garman EF, Oikonomakos NG, Johnson LN. Ternary complex crystal structures of glycogen phosphorylase with the transition state analogue nojirimycin tetrazole and phosphate in the T and R states. Biochemistry. 35: 7341-55. PMID 8652510 DOI: 10.1021/Bi960072W |
0.42 |
|
| 1996 |
Johnson LN, Noble MEM, Owen DJ. Active and inactive protein kinases: Structural basis for regulation Cell. 85: 149-158. PMID 8612268 DOI: 10.1016/S0092-8674(00)81092-2 |
0.6 |
|
| 1995 |
Watson KA, Mitchell EP, Johnson LN, Cruciani G, Son JC, Bichard CJ, Fleet GW, Oikonomakos NG, Kontou M, Zographos SE. Glucose analogue inhibitors of glycogen phosphorylase: from crystallographic analysis to drug prediction using GRID force-field and GOLPE variable selection. Acta Crystallographica. Section D, Biological Crystallography. 51: 458-72. PMID 15299833 DOI: 10.1107/S090744499401348X |
0.392 |
|
| 1995 |
Brown NR, Noble ME, Endicott JA, Garman EF, Wakatsuki S, Mitchell E, Rasmussen B, Hunt T, Johnson LN. The crystal structure of cyclin A. Structure (London, England : 1993). 3: 1235-47. PMID 8591034 DOI: 10.1016/S0969-2126(01)00259-3 |
0.599 |
|
| 1995 |
Oikonomakos NG, Kontou M, Zographos SE, Watson KA, Johnson LN, Bichard CJF, Fleet GWJ, Acharya KR. N-acetyl-β-d-glucopyranosylamine: A potent T-state inhibitor of glycogen phosphorylase. A comparison with α-D-glucose Protein Science. 4: 2469-2477. PMID 8580837 DOI: 10.1002/Pro.5560041203 |
0.391 |
|
| 1995 |
Duke EM, Wakatsuki S, Hadfield A, Johnson LN. Laue and monochromatic diffraction studies on catalysis in phosphorylase b crystals. Protein Science : a Publication of the Protein Society. 3: 1178-96. PMID 7987213 DOI: 10.1002/Pro.5560030804 |
0.578 |
|
| 1995 |
Endicott JA, Noble ME, Garman EF, Brown N, Rasmussen B, Nurse P, Johnson LN. The crystal structure of p13suc1, a p34cdc2-interacting cell cycle control protein Embo Journal. 14: 1004-1014. PMID 7889931 DOI: 10.1002/J.1460-2075.1995.Tb07081.X |
0.603 |
|
| 1995 |
Owen DJ, Papageorgiou AC, Garman EF, Noble MEM, Johnson LN. Expression, purification and crystallisation of phosphorylase kinase catalytic domain Journal of Molecular Biology. 246: 374-381. PMID 7877161 DOI: 10.1006/Jmbi.1994.0092 |
0.61 |
|
| 1995 |
Johnson LN, Barford D. Electrostatic effects in the control of glycogen phosphorylase by phosphorylation. Protein Science : a Publication of the Protein Society. 3: 1726-30. PMID 7849589 DOI: 10.1002/Pro.5560031011 |
0.405 |
|
| 1995 |
Owen DJ, Noble M, Garman EF, Papageorigiou AC, Johnson LN. Two structures of the catalytic domain of phosphorylase kinase: an active protein kinase complexed with substrate analogue and product Structure. 3: 467-482. PMID 7663944 DOI: 10.1016/S0969-2126(01)00180-0 |
0.467 |
|
| 1995 |
Oikonomakos NG, Zographos SE, Johnson LN, Papageorgiou AC, Acharya KR. The binding of 2-deoxy-o-glucose 6-phosphate to glycogen phosphorylase b: Kinetic and crystallographic studies Journal of Molecular Biology. 254: 900-917. PMID 7500360 DOI: 10.1006/Jmbi.1995.0665 |
0.372 |
|
| 1995 |
Board M, Bollen M, Stalmans W, Kim Y, Fleet GWJ, Johnson LN. Effects of C-1-substituted glucose analogue on the activation states of glycogen synthase and glycogen phosphorylase in rat hepatocytes Biochemical Journal. 311: 845-852. PMID 7487940 DOI: 10.1042/Bj3110845 |
0.335 |
|
| 1995 |
Jia Z, Johnson LN. Learning modern protein crystallography Structure. 3: 125. DOI: 10.1016/S0969-2126(01)00141-1 |
0.307 |
|
| 1995 |
Bichard CJF, Mitchell EP, Wormald MR, Watson KA, Johnson LN, Zographos SE, Koutra DD, Oikonomakos NG, Fleet GWJ. Potent inhibition of glycogen phosphorylase by a spirohydantoin of glucopyranose: First pyranose analogues of hydantocidin Tetrahedron Letters. 36: 2145-2148. DOI: 10.1016/0040-4039(95)00197-K |
0.312 |
|
| 1994 |
Watson KA, Mitchell EP, Johnson LN, Son JC, Bichard CJ, Orchard MG, Fleet GW, Oikonomakos NG, Leonidas DD, Kontou M. Design of inhibitors of glycogen phosphorylase: a study of alpha- and beta-C-glucosides and 1-thio-beta-D-glucose compounds. Biochemistry. 33: 5745-58. PMID 8180201 DOI: 10.1021/Bi00185A011 |
0.346 |
|
| 1994 |
Endicott JA, Nurse P, Johnson LN. Mutational analysis supports a structural model for the cell cycle protein kinase p34. Protein Engineering. 7: 243-53. PMID 8170927 DOI: 10.1093/Protein/7.2.243 |
0.42 |
|
| 1994 |
Noble ME, Cleasby A, Johnson LN, Egmond MR, Frenken LG. Analysis of the structure of Pseudomonas glumae lipase. Protein Engineering. 7: 559-62. PMID 8029212 DOI: 10.1093/Protein/7.4.559 |
0.426 |
|
| 1994 |
Hadfield AT, Harvey DJ, Archer DB, MacKenzie DA, Jeenes DJ, Radford SE, Lowe G, Dobson CM, Johnson LN. Crystal structure of the mutant D52S hen egg white lysozyme with an oligosaccharide product Journal of Molecular Biology. 243: 856-872. PMID 7966306 DOI: 10.1006/Jmbi.1994.1688 |
0.383 |
|
| 1994 |
Oikonomakos NG, Kontou M, Zographos SE, Tsitoura HS, Johnson LN, Watson KA, Mitchell EP, Fleet GW, Son JC, Bichard CJ. The design of potential antidiabetic drugs: experimental investigation of a number of beta-D-glucose analogue inhibitors of glycogen phosphorylase. European Journal of Drug Metabolism and Pharmacokinetics. 19: 185-92. PMID 7867660 DOI: 10.1007/Bf03188920 |
0.32 |
|
| 1994 |
Johnson LN. Control by protein phosphorylation Nature Structural Biology. 1: 657-659. PMID 7634063 DOI: 10.1038/Nsb1094-657 |
0.424 |
|
| 1993 |
Taguchi JE, Heyes SJ, Barford D, Johnson LN, Dobson CM. Solid state 31P cross-polarization/magic angle sample spinning nuclear magnetic resonance of crystalline glycogen phosphorylase b. Biophysical Journal. 64: 492-501. PMID 8457673 DOI: 10.1016/S0006-3495(93)81392-4 |
0.3 |
|
| 1993 |
Noble ME, Cleasby A, Johnson LN, Egmond MR, Frenken LG. The crystal structure of triacylglycerol lipase from Pseudomonas glumae reveals a partially redundant catalytic aspartate. Febs Letters. 331: 123-8. PMID 8405390 DOI: 10.1016/0014-5793(93)80310-Q |
0.589 |
|
| 1993 |
Johnson LN, Snape P, Martin JL, Acharya KR, Barford D, Oikonomakos NG. Crystallographic binding studies on the allosteric inhibitor glucose-6-phosphate to T state glycogen phosphorylase b Journal of Molecular Biology. 232: 253-267. PMID 8331662 DOI: 10.1006/Jmbi.1993.1380 |
0.38 |
|
| 1993 |
Leonidas DD, Oikonomakos NG, Papageorgiou AC, Acharya KR, Barford D, Johnson LN. Control of phosphorylase b conformation by a modified cofactor: crystallographic studies on R-state glycogen phosphorylase reconstituted with pyridoxal 5'-diphosphate. Protein Science : a Publication of the Protein Society. 1: 1112-22. PMID 1304390 DOI: 10.1002/Pro.5560010905 |
0.394 |
|
| 1993 |
Barford D, Johnson LN. The molecular mechanism for the tetrameric association of glycogen phosphorylase promoted by protein phosphorylation. Protein Science : a Publication of the Protein Society. 1: 472-93. PMID 1304350 DOI: 10.1002/Pro.5560010403 |
0.376 |
|
| 1993 |
Mitchell EP, Johnson LN, Ermert P, Vasella AT, Withers SG, Oikonomakos NG. Crystallographic studies towards the catalytic mechanism of glycogen phosphorylase Acta Crystallographica Section a Foundations of Crystallography. 49: c87-c87. DOI: 10.1107/S0108767378097512 |
0.303 |
|
| 1993 |
Watson KA, Mitchell EP, Johnson LN, Son JC, Bichard CJF, Fleet GWJ, Ford P, Watkin DJ, Oikonomakos NG. X-Ray crystallographic analysis of 2,6-anhydro-N-methyl-D-glycero-D-ido- heptonamide: The first example of a simple glucose analogue with a skew boat structure Journal of the Chemical Society, Chemical Communications. 654-656. DOI: 10.1039/C39930000654 |
0.313 |
|
| 1992 |
Johnson LN. Glycogen phosphorylase: control by phosphorylation and allosteric effectors. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 6: 2274-82. PMID 1544539 DOI: 10.1096/fasebj.6.6.1544539 |
0.33 |
|
| 1992 |
Duke EMH, Hadfield A, Walters S, Wakatsuki S, Bryan RK, Johnson LN. Time-resolved diffraction studies on glycogen phosphorylase b Philosophical Transactions of the Royal Society A. 340: 245-261. DOI: 10.1098/Rsta.1992.0064 |
0.543 |
|
| 1991 |
Martin JL, Johnson LN, Withers SG. Comparison of the binding of glucose and glucose 1-phosphate derivatives to T-state glycogen phosphorylase b. Biochemistry. 29: 10745-57. PMID 2125493 DOI: 10.1021/Bi00500A005 |
0.38 |
|
| 1991 |
Martin JL, Veluraja K, Ross K, Johnson LN, Fleet GW, Ramsden NG, Bruce I, Orchard MG, Oikonomakos NG, Papageorgiou AC. Glucose analogue inhibitors of glycogen phosphorylase: the design of potential drugs for diabetes. Biochemistry. 30: 10101-16. PMID 1931942 DOI: 10.1107/S0108767378095409 |
0.317 |
|
| 1991 |
Barford D, Hu SH, Johnson LN. Structural mechanism for glycogen phosphorylase control by phosphorylation and AMP. Journal of Molecular Biology. 218: 233-60. PMID 1900534 DOI: 10.1016/0022-2836(91)90887-C |
0.359 |
|
| 1991 |
Duke EM, Hadfield A, Martin JL, Clifton IJ, Hajdu J, Johnson LN, Reid GP, Trentham DR, Bruce I, Fleet GW. Towards time-resolved diffraction studies with glycogen phosphorylase. Ciba Foundation Symposium. 161: 75-86; discussion 86. PMID 1814698 DOI: 10.1002/9780470514146.ch6 |
0.489 |
|
| 1990 |
Hajdu J, Johnson LN. Progress with Laue diffraction studies on protein and virus crystals. Biochemistry. 29: 1669-78. PMID 2184884 DOI: 10.1021/Bi00459A001 |
0.515 |
|
| 1990 |
Johnson LN, Acharya KR, Jordan MD, McLaughlin PJ. Refined crystal structure of the phosphorylase-heptulose 2-phosphate-oligosaccharide-AMP complex. Journal of Molecular Biology. 211: 645-61. PMID 2106586 DOI: 10.1016/0022-2836(90)90271-M |
0.439 |
|
| 1989 |
Barford D, Johnson LN. The allosteric transition of glycogen phosphorylase. Nature. 340: 609-16. PMID 2770867 DOI: 10.1038/340609A0 |
0.392 |
|
| 1989 |
Oikonomakos NG, Acharya KR, Melpidou AE, Stuart DI, Johnson LN. The binding of β-glycerophosphate to glycogen phosphorylase b in the crystal Archives of Biochemistry and Biophysics. 270: 62-68. PMID 2494945 DOI: 10.1016/0003-9861(89)90007-6 |
0.38 |
|
| 1988 |
Oikonomakos NG, Acharya KR, Stuart DI, Melpidou AE, McLaughlin PJ, Johnson LN. Uridine(5')diphospho(1)-alpha-D-glucose. A binding study to glycogen phosphorylase b in the crystal European Journal of Biochemistry. 173: 569-578. PMID 3371347 DOI: 10.1111/J.1432-1033.1988.Tb14037.X |
0.395 |
|
| 1988 |
Dombrádi V, Willis AC, Vereb G, Johnson LN. The sequence around the phosphorylation site of the porcine heart type phosphorylase isoenzyme Comparative Biochemistry and Physiology -- Part B: Biochemistry And. 91: 717-721. PMID 3224509 DOI: 10.1016/0305-0491(88)90198-8 |
0.306 |
|
| 1988 |
Sprang SR, Acharya KR, Goldsmith EJ, Stuart DI, Varvill K, Fletterick RJ, Madsen NB, Johnson LN. Structural changes in glycogen phosphorylase induced by phosphorylation. Nature. 336: 215-21. PMID 3194008 DOI: 10.1038/336215A0 |
0.464 |
|
| 1988 |
Barford D, Schwabe JW, Oikonomakos NG, Acharya KR, Hajdu J, Papageorgiou AC, Martin JL, Knott JC, Vasella A, Johnson LN. Channels at the catalytic site of glycogen phosphorylase b: binding and kinetic studies with the beta-glycosidase inhibitor D-gluconohydroximo-1,5-lactone N-phenylurethane. Biochemistry. 27: 6733-41. PMID 3143403 DOI: 10.1021/Bi00418A014 |
0.559 |
|
| 1988 |
Hajdu J, Acharya KR, Stuart DI, Barford D, Johnson LN. Catalysis in enzyme crystals. Trends in Biochemical Sciences. 13: 104-9. PMID 3072704 DOI: 10.1016/0968-0004(88)90051-5 |
0.549 |
|
| 1988 |
Johnson LN, Cheetham J, McLaughlin PJ, Acharya KR, Barford D, Phillips DC. Protein-oligosaccharide interactions: lysozyme, phosphorylase, amylases. Current Topics in Microbiology and Immunology. 139: 81-134. PMID 2461836 |
0.439 |
|
| 1987 |
Oikonomakos NG, Johnson LN, Acharya KR, Stuart DI, Barford D, Hajdu J, Varvill KM, Melpidou AE, Papageorgiou T, Graves DJ. Pyridoxal phosphate site in glycogen phosphorylase b: structure in native enzyme and in three derivatives with modified cofactors. Biochemistry. 26: 8381-9. PMID 3126802 DOI: 10.1021/Bi00399A053 |
0.58 |
|
| 1987 |
Johnson LN, Acharya KR, Stuart DI, Barford D, Oikonomakos NG, Hajdu J, Varvill KM. Phosphate-recognition sites in catalysis and control of glycogen phosphorylase b. Biochemical Society Transactions. 15: 1001-5. PMID 3121407 DOI: 10.1042/Bst0151001 |
0.526 |
|
| 1987 |
Hajdu J, Machin PA, Campbell JW, Greenhough TJ, Clifton IJ, Zurek S, Gover S, Johnson LN, Elder M. Millisecond X-ray diffraction and the first electron density map from Laue photographs of a protein crystal. Nature. 329: 178-81. PMID 3114644 DOI: 10.1038/329178A0 |
0.542 |
|
| 1987 |
Hajdu J, Acharya KR, Stuart DI, McLaughlin PJ, Barford D, Oikonomakos NG, Klein H, Johnson LN. Catalysis in the crystal: synchrotron radiation studies with glycogen phosphorylase b. The Embo Journal. 6: 539-46. PMID 3107984 DOI: 10.1107/S0108767387084393 |
0.581 |
|
| 1986 |
Oikonomakos NG, Melpidou AE, Johnson LN. Crystallization of pig skeletal phosphorylase b. Purification, physical and catalytic characterization. Biochimica Et Biophysica Acta. 832: 248-56. PMID 3935171 DOI: 10.1016/0167-4838(85)90257-2 |
0.356 |
|
| 1986 |
Hajdu J, Acharya KR, Stuart DI, McLaughlin PJ, Barford D, Klein H, Johnson LN. Time-resolved structural studies on catalysis in the crystal with glycogen phosphorylase b. Biochemical Society Transactions. 14: 538-41. PMID 3089851 DOI: 10.1042/Bst0140538 |
0.551 |
|
| 1985 |
Sansom M, Stuart D, Acharya K, Hajdu J, McLaughlin P, Johnson L. Glycogen phosphorylase b — the molecular anatomy of a large regulatory enzyme Journal of Molecular Structure: Theochem. 123: 3-25. DOI: 10.1016/0166-1280(85)85181-2 |
0.679 |
|
| 1984 |
McLaughlin PJ, Stuart DI, Klein HW, Oikonomakos NG, Johnson LN. Substrate-cofactor interactions for glycogen phosphorylase b: a binding study in the crystal with heptenitol and heptulose 2-phosphate. Biochemistry. 23: 5862-73. PMID 6441595 DOI: 10.1021/Bi00319A028 |
0.41 |
|
| 1984 |
Sansom MS, Babu YS, Hajdu J, Stuart DI, Stura EA, Johnson LN. The role of pyridoxal phosphate in glycogen phosphorylase b; structure, environment and relationship to catalytic mechanism. Progress in Clinical and Biological Research. 144: 127-46. PMID 6427782 |
0.488 |
|
| 1984 |
Lorek A, Wilson KS, Sansom MS, Stuart DI, Stura EA, Jenkins JA, Zanotti G, Hajdu J, Johnson LN. Allosteric interactions of glycogen phosphorylase b. A crystallographic study of glucose 6-phosphate and inorganic phosphate binding to di-imidate-cross-linked phosphorylase b. The Biochemical Journal. 218: 45-60. PMID 6424657 DOI: 10.1042/Bj2180045 |
0.656 |
|
| 1983 |
Stura EA, Zanotti G, Babu YS, Sansom MS, Stuart DI, Wilson KS, Johnson LN, Van de Werve G. Comparison of AMP and NADH binding to glycogen phosphorylase b. Journal of Molecular Biology. 170: 529-65. PMID 6415289 DOI: 10.1016/S0022-2836(83)80160-0 |
0.579 |
|
| 1981 |
Perkins SJ, Johnson LN, Phillips DC, Dwek RA. The simultaneous binding of lanthanide and N-acetylglucosamine inhibitors to hen egg-white lysozyme in solution by 1H and 13C nuclear magnetic resonance. The Biochemical Journal. 193: 573-88. PMID 7305947 DOI: 10.1042/Bj1930573 |
0.543 |
|
| 1981 |
Perkins SJ, Johnson LN, Phillips DC, Dwek RA. The binding of monosaccharide inhibitors to hen egg-white lysozyme by proton magnetic resonance at 270 MHz and analysis by ring-current calculations. The Biochemical Journal. 193: 553-72. PMID 7305946 DOI: 10.1042/Bj1930553 |
0.567 |
|
| 1981 |
Stuart DI, Wilson KS, Stura EA, Wild DL, Jenkins JA, Johnson LN. Glycogen phosphorylaseb: structure determination and refinement Acta Crystallographica Section a Foundations of Crystallography. 37: C35-C35. DOI: 10.1107/S0108767381098553 |
0.339 |
|
| 1980 |
Johnson LN, Jenkins JA, Wilson KS, Stura EA, Zanotti G. Proposals for the catalytic mechanism of glycogen phosphorylase beta prompted by crystallographic studies on glucose 1-phosphate binding. Journal of Molecular Biology. 140: 565-80. PMID 6776286 DOI: 10.1016/0022-2836(80)90271-5 |
0.381 |
|
| 1980 |
Johnson LN, Stura EA, Wilson KS, Sansom MS, Weber IT. Nucleotide binding to glycogen phosphorylase b in the crystal. Journal of Molecular Biology. 134: 639-53. PMID 119868 DOI: 10.1016/0022-2836(79)90371-1 |
0.573 |
|
| 1979 |
Perkins SJ, Johnson LN, Machin PA, Phillips DC. Crystal structures of hen egg-white lysozyme complexes with gadolinium(III) and gadolinium(III)-N-acetyl-D-glucosamine. The Biochemical Journal. 181: 21-36. PMID 486153 DOI: 10.1042/Bj1810021 |
0.559 |
|
| 1978 |
Johnson LN, Wilson KS, Weber IT, Wild DL, Jenkins JA, Stura EA. Crystallographic studies on the structure and function of glycogen phosphorylase b. Biochemical Society Transactions. 6: 1108-11. PMID 744367 DOI: 10.1042/Bst0061108 |
0.314 |
|
| 1978 |
Perkins SJ, Johnson LN, Machin PA, Phillips DC. Crystal structures of egg-white lysozyme of hen in acetate-free medium and of lysozyme complexes with N-acetylglucosamine and beta-methyl N-acetylglucosaminide. The Biochemical Journal. 173: 607-16. PMID 697738 DOI: 10.1042/Bj1730607 |
0.559 |
|
| 1978 |
Weber IT, Johnson LN, Wilson KS, Yeates DG, Wild DL, Jenkins JA. Crystallographic studies on the activity of glycogen phosphorylase b. Nature. 274: 433-7. PMID 672971 DOI: 10.1038/274433A0 |
0.442 |
|
| 1978 |
Johnson L, Weber I, Wild D, Wilson K, Yeates D. Crystallographic analysis at low resolution of metabolite binding sites on phosphorylase b Journal of Molecular Biology. 118: 579-591. DOI: 10.1016/0022-2836(78)90290-5 |
0.376 |
|
| 1977 |
Perkins SJ, Johnson LN, Phillips DC, Dwek RA. Conformational changes, dynamics and assignments in 1H NMR studies of proteins using ring current calculations. Hen egg white lysozyme. Febs Letters. 82: 17-22. PMID 562276 DOI: 10.1016/0014-5793(77)80876-4 |
0.497 |
|
| 1977 |
Blake CC, Grace DE, Johnson LN, Perkins SJ, Phillips DC, Cassels R, Dobson CM, Poulsen FM, Williams RJ. Physical and chemical properties of lysozyme. Ciba Foundation Symposium. 137-85. PMID 252451 |
0.476 |
|
| 1977 |
Perkins SJ, Johnson LN, Phillips DC, Dwek RA. High resolution 1H- and 13C-N.M.R spectra of D-glucopyranose, 2-acetamido-2-deoxy-D-glucopyranose, and related compounds in aqueous media Carbohydrate Research. 59: 19-34. DOI: 10.1016/S0008-6215(00)83289-9 |
0.493 |
|
| 1974 |
Ford LO, Johnson LN, Machin PA, Phillips DC, Tjian R. Crystal structure of a lysozyme-tetrasaccharide lactone complex. Journal of Molecular Biology. 88: 349-71. PMID 4453000 DOI: 10.1016/0022-2836(74)90487-2 |
0.573 |
|
| 1974 |
Johnson LN, Madsen NB, Mosley J, Wilson KS. The crystal structure of phosphorylase beta at 6 A resolution. Journal of Molecular Biology. 90: 703-17. PMID 4449138 DOI: 10.1016/0022-2836(74)90534-8 |
0.399 |
|
| 1972 |
Eagles PAM, Iqbal M, Johnson LN, Mosley J, Wilson KS. A tetragonal crystal form of phosphorylase b Journal of Molecular Biology. 71. PMID 4648349 DOI: 10.1016/S0022-2836(72)80042-1 |
0.319 |
|
| 1972 |
Imoto T, Johnson LN, North ACT, Phillips DC, Rupley JA. 21 Vertebrate Lysozymes Enzymes. 7: 665-868. DOI: 10.1016/S1874-6047(08)60465-5 |
0.391 |
|
| 1969 |
Johnson L. Structural aspects of enzymatic activity A report of the british biophysical society meeting held in London on 17 and 18 December 1968 Febs Letters. 2: 201-205. DOI: 10.1016/0014-5793(69)80019-0 |
0.314 |
|
| 1968 |
Johnson LN, Phillips DC, Rupley JA. The activity of lysozyme: an interim review of crystallographic and chemical evidence. Brookhaven Symposia in Biology. 21: 120-38. PMID 4889241 |
0.417 |
|
| 1967 |
Wyckoff HW, Doscher M, Tsernoglou D, Inagami T, Johnson LN, Hardman KD, Allewell NM, Kelly DM, Richards FM. Design of a diffractometer and flow cell system for X-ray analysis of crystalline proteins with applications to the crystal chemistry of ribonuclease-S. Journal of Molecular Biology. 27: 563-78. PMID 6049685 DOI: 10.1016/0022-2836(67)90059-9 |
0.541 |
|
| 1967 |
Wyckoff HW, Hardman KD, Allewell NM, Inagami T, Tsernoglou D, Johnson LN, Richards FM. The structure of ribonuclease-S at 6 A resolution. The Journal of Biological Chemistry. 242: 3749-53. PMID 6038503 |
0.487 |
|
| 1967 |
Wyckoff HW, Hardman KD, Allewell NM, Inagami T, Johnson LN, Richards FM. The structure of ribonuclease-S at 3.5 A resolution. The Journal of Biological Chemistry. 242: 3984-8. PMID 6037556 |
0.487 |
|
| 1967 |
Johnson LN. An interaction between lysozyme and penicillin. Proceedings of the Royal Society of London. Series B, Biological Sciences. 167: 439-40. PMID 4382808 DOI: 10.1098/Rspb.1967.0042 |
0.32 |
|
| 1967 |
Blake CC, Johnson LN, Mair GA, North AC, Phillips DC, Sarma VR. Crystallographic studies of the activity of hen egg-white lysozyme. Proceedings of the Royal Society of London. Series B, Biological Sciences. 167: 378-88. PMID 4382801 DOI: 10.1098/Rspb.1967.0035 |
0.532 |
|
| 1965 |
Johnson LN, Phillips DC. Structure of some crystalline lysozyme-inhibitor complexes determined by X-ray analysis at 6 Angstrom resolution. Nature. 206: 761-3. PMID 5840126 DOI: 10.1038/206761A0 |
0.546 |
|
| 1964 |
JOHNSON LN, PHILLIPS DC. CRYSTAL STRUCTURE OF N-ACETYLGLUCOSAMINE. Nature. 202: 588. PMID 14195059 DOI: 10.1038/202588A0 |
0.559 |
|
| Show low-probability matches. |
